chrisvoncsefalvay/vaers-outcomes huggingface dataset:
After a little more than 24 hours a red, circular welt appeared on my skin at the injection site. It was hard and hot to the touch. After another 24 hours the welt doubled in size. It's still hard and hot to the touch. It feels tender but doesn't itch.
LIGHTHEADED; ABDOMINAL PAIN; FELT AS THOUGH A BAD HANGOVER X 4 DAYS; TIREDNESS; This spontaneous report received from a patient concerned a 63 year old male. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included the patient had no known allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1802068 expiry: UNKNOWN) dose was not reported, administered on 26-MAR-2021 vaccinated on left arm for prophylactic vaccination. No concomitant medications were reported. On 28-MAR-2021, the subject experienced lightheaded. On 28-MAR-2021, the subject experienced abdominal pain. On 28-MAR-2021, the subject experienced felt as though a bad hangover x 4 days. On 28-MAR-2021, the subject experienced tiredness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from tiredness, and lightheaded, and the outcome of abdominal pain and felt as though a bad hangover x 4 days was not reported. This report was non-serious.; Sender's Comments: V0 Medical assessment comment not required as per standard operating procedure as the case assessed as non-serious.
Fever (99.7) body aches, HA, mild diarrhea, fatigue started midnight, symptoms improved with Tylenol.
Finger prick while handling adjuvant vial of Shingrix vaccine; Inadvertent exposure to vaccine; exposure via skin contact; This case was reported by a pharmacist via call center representative and described the occurrence of laceration of finger in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, immediately after receiving Shingrix, the patient experienced laceration of finger, inadvertent exposure to vaccine and exposure via skin contact. On an unknown date, the outcome of the laceration of finger, inadvertent exposure to vaccine and exposure via skin contact were unknown.   It was unknown if the reporter considered the laceration of finger to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not applicable for this report. The pharmacist who reported finger prick while handling adjuvant vial of Shingrix vaccine, which led to laceration of finger, inadvertent exposure to vaccine and exposure via skin contact. The caller declined to provide more information for GlaxoSmithKline safety report and mentions she has reported it to her corporate department.  Limited details were provided.
TEMP. 101.8, HEADACHE, MALAISE, BODY ACHES, CHILLS
27 minutes after the shot of Pfizer/BioNTech Covid vaccination, I felt a systemic change throughout my body of acute onset.  It lasted for 4 minutes.  It is difficult to describe and I never felt anything like that before.  It was NOT fatigue, nausea, dizziness, difficulty breathing, heat, cold, or a feeling of tightness.  I had no blurred vision, rash or itchiness.  However, the feeling was physical and strong, experienced throughout my body.  The best I could describe would be a flush without heat and a sensation that something was going very wrong.  I took my pulse which was about 84.
Child developed mouth swelling, facial swelling, and difficulty breathing. Child was evaluated and treated at Hospital emergency department. Child was given Benadryl.
loss of taste after covid vaccine; She is panicked; This is a spontaneous report from a non-contactable consumer or other non-health professional (patient). A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/lot number, NDC number and Expiry date are not provided), via an unspecified route of administration on 09Mar2021 as dose 1, single for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. Investigation assessment was not provided. It was reported that she received her first Covid vaccine the previous day on 09Mar2021 and woke this morning 10Mar2021 and was experiencing some loss of taste. She contacted her physician this morning and her doctor told her to call Pfizer. She wanted to know what to do next. She was panicked on 10Mar2021. And the loss of taste is not a side effect. She could smell things just has a loss of taste. The outcome of events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was reported.     On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm). At the time of the report, PAIN IN EXTREMITY (sore arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       NO concomitant medication was provided. no treatment details was included.
inflammation; really hot; delayed reaction; intensely itching at the site; red; swollen/ area was the size of a grapefruit in circumference; This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of INFLAMMATION (inflammation), VACCINATION SITE WARMTH (really hot), SKIN REACTION (delayed reaction), VACCINATION SITE PRURITUS (intensely itching at the site) and VACCINATION SITE ERYTHEMA (red) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 12-Jan-2021 at 9:30 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INFLAMMATION (inflammation), VACCINATION SITE WARMTH (really hot), SKIN REACTION (delayed reaction), VACCINATION SITE PRURITUS (intensely itching at the site), VACCINATION SITE ERYTHEMA (red) and VACCINATION SITE SWELLING (swollen/ area was the size of a grapefruit in circumference). At the time of the report, INFLAMMATION (inflammation) had resolved and VACCINATION SITE WARMTH (really hot), SKIN REACTION (delayed reaction), VACCINATION SITE PRURITUS (intensely itching at the site), VACCINATION SITE ERYTHEMA (red) and VACCINATION SITE SWELLING (swollen/ area was the size of a grapefruit in circumference) was resolving. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Company Comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
gave only the powder HIB portion/ DTaP-IPV portion of Pentacel was not administered, with no reported adverse event; Initial information was received on 01-Oct-2021 regarding an unsolicited valid non-serious case received from an other health professional via consumer via phone (under Medical Information Inquiry Number: 00794918).  This case involves a two-month-old female patient who was given only the powder hib portion/ dtap-ipv portion of DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(VERO)/HIB(PRP/T) VACCINE [PENTACEL (VERO)] was not administered (product preparation error).  The patient's medical history, past medical treatments, vaccinations and family history were not provided.  Concomitant medications included PNEUMOCOCCAL VACCINE CONJ 7V (CRM197) (PREVNAR) and ROTAVIRUS VACCINE (ROTAVIRUS VACCINE) for prophylactic vaccination.  On 01-Oct-2021, the patient received a 0.5 ml dose of suspect DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(VERO)/HIB(PRP/T) VACCINE lot UJ529AAA and expiry date: 22-Jul-2022 via unknown route in the left thigh for prophylactic vaccination.  It was an actual medication error due to wrong diluent used (same day).  It was reported "Caller reported giving PENTACEL to a child and only used the HIB portion with a diluent. Caller was asking what to do from here. A Medical Assistant gave only the powder HIB portion. The diluent that was used was sterile water. The DTaP-IPV portion of Pentacel was not administered. The caller asked what should be done. Was there any adverse effect of giving the HIB portion diluted with sterile water. Later, another Medical Assistant went to the vaccination supply and found that there was an extra Pentacel diluent by itself in there without the powder, and that was how the error was discovered."  At the time of reporting, no adverse event reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Initial report received from a health care professional on 17 September 2010. A group of 17 unidentified patients received on an unknown date an injection (sites and routes not provided) of ADACEL, lot numbers unknown. A pharmacy tech reported that 40 employees at a long term facility were given ADACEL. Days following the vaccine, fifteen patients had bad swelling, redness, itching, burning and local pain at injection site. Two patients were sent to the emergency room for cellulitis. The outcome was reported as unknown. Documents held by sender: None.
When I move my left arm in many positions, my arm feels as if a needle is in it--sharp, intense pain. (There is no actual needle or other foreign body, just the feeling.)  This has persisted for two months.
Patient reported that site was initially swollen and itchy. She understood that was a possible reaction. However, over 2 months have passed and she still has a bump the size of a mosquito bite there, and it still itches. Reported no other problems.
Two days after vaccine, I developed a very bad rash in and around both armpits and over my upper torso. I used an anti-itch cream on the areas, but the rash remained. The rash was red in color. The area felt both hot and itchy. The itching and rash lasted for nearly 4 weeks before clearing up. I delayed in reporting this because I was in the middle of a major move at the time. I relocated from during this time period. I continued to monitor the rash and it subsided on its own after 4 weeks, but I was prepared to visit a medical professional if things got worse.
neck pain, aches, headache, dizziness, tachycardia, sweats, nausea
8 hours after vaccination with Johnson and Johnson brand , the fever started, its now 32 hours passed and the fever does not go away and it somewhat under control with ibuprofen and acetaminophen
Pt received his first dose of Pfizer vaccine on 1/26/2021 from a pharmacy.  He reportedly had Bell's Palsy sometime after this first dose.  He was was brought to Health Department off site Covid Vaccine Clinic at local market.   He had a caregiver with him and was currently staying at a rehabilitation facility.  The facility had signed the patient up for his first dose of Moderna unaware that he had received a dose of Pfizer in January.  The patient stated that he had received a dose previously.  The caregiver stated that the patient had not received a first dose, and contacted the facility to confirm this.  The vaccinator verified this with a supervisor, and then proceeded to administer a dose of Moderna vaccine.  The facility realized that the patient had a previous dose of Pfizer on 3/15/2021 and the Health Department.  The patient was reportedly doing well and his primary care provided had been notified on the evening of 3/15/2021.
After the booster shot on the 9th of September, 2021, I lost my hearing in my left ear and passed out in the pharmacy parking lot. Was taken to the hospital vomiting,dizziness etc.
PATIENT HAS REDNESS AT INJECTION SITE. POSSIBLE ALLERGIC REACTION.
Patient was given the Pfizer vaccine intramuscularly in her left arm. As soon as the needle was withdrawn her eyes rolled over and she slumped in her chair. We ( myself, her mother and her father) where in the process of placing her on the floor when she indicated that she wanted to get up. We placed her back into her seat and her mother proceeded to rub her back. I asked her if she needed anything but she declined. I kept her for observation for 30 minutes monitoring for any signs of shortness of breath, wheezing or swelling of the tongue or throat. No symptoms were observed. I advised her mother to notify patient's pediatrician of the incident and then released the patient.
Body aches and soreness. Started in am and progresses as day went on. A headache. Took Tylenol extra strength 2 times. Q 6 hrs.
This spontaneous report as received from a nurse refers to approximately 15 years old patient of unknown gender. Information regarding the patient's medical history, concurrent conditions, drug reactions/allergies and concomitant medications were not provided. Nurse reported that on 28-MAY-2015, the patient was vaccinated with first dose of with GARDASIL 9 (lot# K007826, expiry date: not reported) at the age of 13 years, for prophylaxis. The patient received second vaccine dose on 20-JUL-2016, which was outside of the dosage recommendations in the product prescribing information. No adverse effect was reported. Additional information has been requested.
Moderna vaccine #1 administered to minor under the age of 18 (16, almost 17 years of age at time of vaccination). No immediate adverse reactions, no signs/symptoms noted.
ADMINISTERED EARLIER THAN THE RECOMMENDED 21 DAY INTERVAL. DOSE ONE OF PFIZER/BIONTECH (LOT #30135BA) WAS ADMINISTERED TO PATIENT ON 09/22/2021 (LEFT ARM, DELTOID, IM).  DOSE TWO OF PFIZER/BIONTECH (LOT #FE3590 WAS ADMINISTERED TO PATIENT 5 DAYS TOO EARLY ON 10/08/2021 (LEFT ARM, DELTOID, IM).   PATIENT HAD NO ADVERSE REACTION. VAERS REPORT SUBMITTED TO RECORD EARLY VACCINATION.
No adverse event; MMR-II was given on 22-AUG-2019 and VARIVAX given on 27-AUG-2019; This spontaneous report was received from physician and referring to a 6-year-old male patient. The patient's pertinent medical history, previous drug reactions or allergies and concomitant medications were not reported.  On 22-AUG-2019, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II), lot number: R031680, expiration date:1-NOV-2020 ,administered intramuscularly for prophylaxis (strength, and expiration date were not provided)(inappropriate schedule of product administration).  On 27-AUG-2019, the patient was vaccinated therapy with varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous lot number: S002396, expiration date: 23-JAN-2021, administered intramuscularly for prophylaxis (strength was not provided). On 27-NOV-2021, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD), lot number: S017251, expiration date: 01-DEC-2020, administered for prophylaxis (strength, and route of administration were not provided).
3/14/2021: Presented with multiple foul-smelling watery stools per day, generalized abdominal pain, and son reports low oxygen levels of 89% at home after testing positive for Covid-19 earlier in the week. Of note, the patient lives in a household with 6 other people who have tested positive for Covid-19. The patient remains admitted at the time of this report requiring supplemental oxygen (2L).
Patient had bone and muscle pain in joints and extremities with the left side being worse. Patient also had nausea and decreased appetite. Patient experienced fatigue, muscle flaccidity in upper left thigh and neuropathy in both hands
I had a sore arm after receiving the vaccine for about a day. I started feeling symptoms on 03/14/2023. I tested positive for COVID-19 on 03/19/2023. I contacted my doctor and got a prescription for PAXLOVID, but I started feeling better without and I did not take it. I took ADVIL to help with the headache and fever. As of today, I do not have any lingering symptoms of COVID-19.
This spontaneous report was received from a nurse refers to 5 unspecified patients of unknown age and gender. No concurrent condition or medical history was reported. On an unknown date the 4 patients were vaccinated with improperly stored PROQUAD (Merck) (lot # L030588, exp. 10-FEB-2017, dose and route of administration not provided) and 1 patient was vaccinated with PROQUAD (Merck) (lot # L031603, exp. 18-FEB-2017, dose and route of administration not provided). No concomitant therapy was reported, No adverse effects were reported. The outcome of the event was unknown. No product quality issue was involved. This is one of the two reports from the same reporter link. Additional information has been requested.
Vaccine administration error related to temperature excursion from recommended storage temperature, not known to this writer to be associated with an adverse event. The clinic has relayed to this writer that prior to the vaccine's thawing and administration to the vaccine recipient, the administered vaccine was stored in frozen temperatures for longer than recommended by the manufacturer. (This VAERS writer assigned to form completion was not the administrator of this vaccine).
Hypotonic-hyporesponsive episode for 2 min; pallor for 15 min; Mom reported events next morning;
Sinus Tachycardia/SVT/Palpitations. Ongoing since January - Racing Heart -Heart beating hard -Shortness of breath -Dizziness
pt recvd flu vax & pt exp flu-like sx including nausea, vomiting & achiness;
19APR97 some clusters of raised rash appeared on face on chest & back;no fever;21APR97 vomiting x 4 during day & x 2 @ HS;22APR97 mom states rash is starting to disappear & pt was able to eat breakfast;no throwing up;has a call into clinic;
dev chest pain, dyspnea, exercise intolerance starting 4-5 days after second shot.  Symptoms progressed over the next couple weeks.
Patient presented asking for 1st COVID-19 vaccination on 07/31/21. Vaccination was administered with Pfizer.  Public Health called and said this patient had already received 2 doses of the Pfizer vaccine on 02/05/2021 and 02/26/21.  No adverse events reported at this time.
Four minutes later after the dose, my throat and eyes started to itch. My face turned reddish started to itch. About fifteen minutes later I began to feel numbness in my lips and tongue. After 30 minutes my lips and tongue swelled, a few minutes later I couldn't swallow. I took antihistamines (BENADRYL) every four hours for two days. Little by little it was relieved although it lasted about two days. In the course, my lips started burning and they peeled. 6 to 7 months later, I had welts all over my body (especially on the trunk, arms, and legs). It lasted about a month and the doctors who treated me think that it was probably due to the vaccine.
It is July 26, 2021. I have had hives everyday since 04/16/2021. I have been seen in the emergency room. I have been seen by a family doctor. I have been seen by a Dermatologist. I have had a biopsy confirming the hives. I have taken antihistamines and steroids. They will not go away. Some days are worse than others. I had hives for one day after my first Covid shot on 03/24/2021. I have had hives every single day since my second Covid shot on 04/16/2021.
1st dose on Monday and started having symptoms of a yeast infection on Thursday; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administration date Nov2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: FUNGAL INFECTION (non-serious) with onset Nov2021, outcome "unknown", described as "1st dose on Monday and started having symptoms of a yeast infection on Thursday".  The lot number for bnt162b2 was not provided and will be requested during follow up.
Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 03-Mar-2022.; Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 03-Mar-2022.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 03-Mar-2022.) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 03-Mar-2022.) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2022 at 7:18 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 03-Mar-2022 at 7:18 PM,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 03-Mar-2022.). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 03-Mar-2022.). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 03-Mar-2022.) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 03-Mar-2022.) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The patient's ethnicity was reported as Asian.  No Concomitant product use was reported.  The patient received vaccine past its 30 day expiry date The vaccine went into 2-8 degree Celsius thaw state on or about 24-Dec-2021. The vaccine was administered up until it manufactured expiry date of 04-Apr-2022. The patient received booster dose.  No treatment information was provided.
She was eating after the vaccine which started as a stiffness, down both of her shoulders and into her waist, severe nauea and headache. She felt like her feet were in cinderblocks.  She took some Tylenol, and woke up at 4:00 AM and had two severe headaches and nausea since Sunday.  That night she felt as though she could not stand it any longer.  Went to UC and they tested her for the virus which was negative, and still having symptoms.  She thought the symptoms would get less, but it has been quite a few days.  She takes a short walk and the intense pain in her arms, and legs are terrible.   Her PCP told her that there was nothing they could do, and what she had been doing what she needed to do.  They also told her to go back to UC if she did not improve.
Pt received the second dose at an interval of 25 days instead of the recommended 28 days